Drug Boosts PSMA-PET Signal for Prostate Cancer in Small Study

(MedPage Today) -- A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a subset of patients with high-risk localized prostate cancer, according to findings from the phase II Daro...
Source
MedPage Today
Opens original article in a new tab



